231 related articles for article (PubMed ID: 22038398)
1. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.
Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M
Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398
[TBL] [Abstract][Full Text] [Related]
2. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A
Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014
[TBL] [Abstract][Full Text] [Related]
4. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway].
Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P
Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells.
Zhou ZW; Li XX; He ZX; Pan ST; Yang Y; Zhang X; Chow K; Yang T; Qiu JX; Zhou Q; Tan J; Wang D; Zhou SF
Drug Des Devel Ther; 2015; 9():1511-54. PubMed ID: 25834399
[TBL] [Abstract][Full Text] [Related]
6. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways.
Lim W; Park S; Bazer FW; Song G
J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer.
Wu Z; Zhu Q; Yin Y; Kang D; Cao R; Tian Q; Zhang Y; Lu S; Liu P
Cancer Med; 2018 Apr; 7(4):1546-1559. PubMed ID: 29533017
[TBL] [Abstract][Full Text] [Related]
8. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway.
Chen E; Chen C; Niu Z; Gan L; Wang Q; Li M; Cai X; Gao R; Katakam S; Chen H; Zhang S; Zhou R; Cheng X; Qiu Y; Yu H; Zhu T; Liu J
Signal Transduct Target Ther; 2020 Nov; 5(1):216. PubMed ID: 33154351
[TBL] [Abstract][Full Text] [Related]
9. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
Inao T; Harashima N; Monma H; Okano S; Itakura M; Tanaka T; Tajima Y; Harada M
Breast Cancer Res Treat; 2012 Jul; 134(1):89-100. PubMed ID: 22203435
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.
Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H
Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222
[TBL] [Abstract][Full Text] [Related]
12. Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.
Palchetti S; Starace D; De Cesaris P; Filippini A; Ziparo E; Riccioli A
J Biol Chem; 2015 Feb; 290(9):5470-83. PubMed ID: 25568326
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
14. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N
Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.
Qi W; Morales C; Cooke LS; Johnson B; Somer B; Mahadevan D
Oncotarget; 2015 Dec; 6(39):41976-87. PubMed ID: 26506516
[TBL] [Abstract][Full Text] [Related]
17. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
18. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
19. Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition.
Zhu X; Chen X; Wang G; Lei D; Chen X; Lin K; Li M; Lin H; Li D; Zheng Q
Biol Pharm Bull; 2022; 45(8):1027-1035. PubMed ID: 35908886
[TBL] [Abstract][Full Text] [Related]
20. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C
Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]